Amy Denkins, APRN
Primary Care · Adrian, MINPI 1174176275
Payments from drug & device makers
Across 44 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$162
- Lilly USA, LLC$120
- AbbVie$103
- GSK$91
- Pfizer$72
- AstraZeneca$56
- plus $189 from 6 others
What the payments were for
- Food & beverage$793100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $162 |
| Lilly USA, LLC | 6 | $120 |
| AbbVie | 6 | $103 |
| GSK | 4 | $91 |
| Pfizer | 4 | $72 |
| AstraZeneca | 4 | $56 |
| Amgen | 3 | $52 |
| Boehringer Ingelheim | 3 | $49 |
| Merck | 2 | $36 |
| Boston Scientific | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
How this compares
$793 in reported general payments places this provider in the 65th percentile of 292 primary care providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 52 | $844 |
| Levothyroxine Sodium | 65 | $629 |
| Losartan Potassium | 46 | $553 |
| Omeprazole | 36 | $517 |
| Rosuvastatin Calcium | 15 | $473 |
| Celecoxib | 11 | $395 |
| Simvastatin | 37 | $381 |
| Amlodipine Besylate | 36 | $350 |
| Lisinopril | 44 | $323 |
| Cephalexin | 42 | $310 |
| Metformin Hcl | 30 | $208 |
| Sertraline Hcl | 15 | $207 |
| Metoprolol Succinate | 14 | $202 |
| FenofibrateFenofibrate Nanocrystallized | 11 | $199 |
| Hydrochlorothiazide | 32 | $173 |
Paid to pharmacies, not to this prescriber.
Other primary care in Adrian
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
- Katherine HouleMarquette$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.